Sign in to view content

Potential Safety Concerns of Bevacizumab

Robert L. Avery, MD

Video
Published 2017

Related

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
Torpedo Maculopathy
Yoshihiro Yonekawa, MD, FASRS
Retina Image Bank: Images of the Week
2020
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Annual Meeting Talks
2019

Category: Pediatric Retina - ROP

See more